Gastric Carcinomas Localized to the Cardia
Author(s) -
Karin E. Bakkelund,
Ivar S. Nordrum,
Reidar Fossmark,
Helge L. Waldum
Publication year - 2012
Publication title -
gastroenterology research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 45
eISSN - 1687-630X
pISSN - 1687-6121
DOI - 10.1155/2012/457831
Subject(s) - chromogranin a , enterochromaffin cell , medicine , synaptophysin , gastric cardia , histidine decarboxylase , enterochromaffin like cell , immunohistochemistry , neuroendocrine tumors , adenocarcinoma , gastroenterology , neuroendocrine tumour , gastrin , pathology , serotonin , stomach , gastric acid , cancer , enzyme , biology , histidine , receptor , biochemistry , secretion
Objectives . Gastric adenocarcinomas localized to the cardia are increasing. Enterochromaffin-like (ECL) cells play a role in gastric carcinogenesis in hypergastrinemia, and the use of proton pump inhibitors (PPI) leading to hypergastrinemia has increased considerably during the last decades. We have examined cardia cancers for neuroendocrine and ECL cell differentiation. Methods . Thirty-two cardia cancers were examined by immunohistochemical labelling of chromogranin A (CgA), synaptophysin, serotonin, and histidine decarboxylase (HDC). Information about PPI use was collected from the patient records. Results . In 15 of 32 tumours, there were positive signs for one or several neuroendocrine markers. Five cases were CgA and serotonin positive; three of these carcinomas were also positive for HDC. Three patients were long-term users of PPI, and two of these were immunoreactive for neuroendocrine markers. Conclusions . A high proportion of cardia cancers expressed neuroendocrine markers, but only few patients with cardia cancers were using PPI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom